Ncezid topic 031 - phase i development of sherlock assay

Ended Definitive Contract Awarded Last action

Contract number
75D30124C19752
Awardee
Awarding agency
Obligated
$243,500

Award facts

Contract value 100% obligated
$243,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a $243,500.00 firm fixed-price Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Innotech Precision Medicine, Inc., a woman-owned small business, for the Phase I development of the SHERLOCK assay under the NCEZID TOPIC 031 program. The contract has a total small business set-aside designation and an ultimate completion date of March 9, 2025. The place of performance is Atlanta, Georgia.

Quick answers

Who was awarded contract 75D30124C19752?

75D30124C19752 was awarded to Innotech Precision Medicine, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 9, 2024.

How much is contract 75D30124C19752 worth?

The government has obligated $243,500 on 75D30124C19752.

Was contract 75D30124C19752 competed?

The extent of competition for 75D30124C19752 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login